Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Voyager Cheers End Of Sanofi Partnership In Parkinson's; Investors Less Confident

Nov 01 2017

• By Mandy Jackson

DNA detail background with selective focus

Related Content

Third Rock funds gene therapy startup Voyager with $45m

Feb 13 2014

Voyager's Parkinson's Gene Therapy Poised For Pivotal Trial Exploration

Sep 06 2017

Biotech IPO Window Closed In November As Returns And Prices Plunged

Dec 03 2015

Genzyme commits $100m upfront for Voyager's gene therapy expertise in CNS

Feb 12 2015

Related Companies

Voyager Therapeutics, Inc

Sanofi

Additional Topics

Deals Business Strategies Commercial Neurology BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window